Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ACTIVE NOT RECRUITING

Remote Speech and Swallowing Assessment in ALS

NCT04889898 · View on ClinicalTrials.gov ↗

Study Summary

The investigators propose a longitudinal home study of ALS patients to measure the severity of speech and swallowing (bulbar) impairment via a smartphone-based, remote speech and swallow assessment (rSSA). The study is designed to assess the feasibility and validity of such a monitoring intervention. Furthermore, it is proposed that regular monitoring of these two bulbar processes may shed light on their co-evolution over the course of ALS.

Interventions

  • DEVICE Digital recording of speech and swallow sounds using the Beiwe Digital Health App on a personal smartphone
  • RADIATION Modified Barium Swallow Study (MBSS)
  • BEHAVIORAL Speech Intelligibility Test (SIT)
  • BEHAVIORAL SIT Scoring

Study Locations (1)

Pennsylvania

  • Hershey Medical Center ALS Clinic — Hershey

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2022-01-01
Est. Completion 2026-09

Sponsor

Milton S. Hershey Medical Center

277 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04889898

The ClinicalTrials.gov registry entry for NCT04889898 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 277 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 4 interventions — of which Digital recording of speech and swallow sounds using the Beiwe Digital Health App on a personal smartphone is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT04889898 reports 1 study location spanning 1 distinct geographic area — top geographies include Pennsylvania. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT04889898 about?

NCT04889898 is a clinical study titled "Remote Speech and Swallowing Assessment in ALS". The investigators propose a longitudinal home study of ALS patients to measure the severity of speech and swallowing (bulbar) impairment via a smartphone-based, remote speech and swallow assessment (rSSA). The study is designed to assess the feasibility and validity of such a monitoring intervention...

What is the current status of trial NCT04889898?

This trial is currently active not recruiting. The enrollment target is 170 participants. The study started on 2022-01-01. Estimated completion is 2026-09.

What conditions does trial NCT04889898 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT04889898?

The interventions under investigation include: Digital recording of speech and swallow sounds using the Beiwe Digital Health App on a personal smartphone (DEVICE), Modified Barium Swallow Study (MBSS) (RADIATION), Speech Intelligibility Test (SIT) (BEHAVIORAL), SIT Scoring (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT04889898?

This trial is sponsored by Milton S. Hershey Medical Center, which has 277 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT04889898 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial